期刊文献+

不同中心静脉输液途径对乳腺癌患者置管并发症发生的影响 被引量:13

Effects of different approaches to central venous catheterization on complication incidence of breast tumor
下载PDF
导出
摘要 目的比较乳腺癌患者采用外周静脉穿刺中心静脉置管(peripherally inserted central catheter,PICC)和植入式静脉输液港(venous port access,VPA)置管期间并发症的发生率,探讨乳腺癌患者合适的中心静脉输液途径。方法选取2012年1月-2014年1月本院收治的乳腺癌化疗患者409例,将植入VPA的191例设为VPA组,植入PICC的218例设为PICC组,比较两组患者置管期间并发症发生情况。结果 VPA组患者置管期间并发症总发生率低于PICC组患者(P〈0.05)。结论VPA具有安全、舒适的优点,是乳腺癌患者静脉输液的理想途径。 Objective To compare the effects of peripherally inserted central catheter(PICC) and venous port access(VPA) on the complication incidence of breast cancer.Methods A total of 191 breast cancer patients with VPA and 218 ones with PICC for chemotherapy from January 2012 to January 2014 were involved.The two groups were compared in respect of incidence of complications during intubation.Result The complication incidence in the VPA group was lower than the PICC group(P〈0.05).Conclusion VPA is an ideal pathway for intravenous infusion in breast cancer patients undergoing chemotherapy.
出处 《现代临床护理》 2014年第8期40-43,共4页 Modern Clinical Nursing
关键词 乳腺癌 外周静脉穿刺中心静脉置管 植入式静脉输液港 并发症 breast cancer PICC venous port access complications
  • 相关文献

参考文献18

二级参考文献95

共引文献351

同被引文献154

  • 1苏琳虹,何海艳.植入式中心静脉输液港与PICC在乳腺癌患者中护理的对比研究[J].医学信息(医学与计算机应用),2014,0(6):191-191. 被引量:10
  • 2李丽,吕海芳,尚彦,周芳.植入式静脉输液港与PICC在护理实践中的应用[J].全科护理,2012,10(21):1964-1965. 被引量:5
  • 3冯志英,王建荣,张黎明,马燕兰,魏畅,郭俊艳.住院患者护理工作满意度量表的研制[J].中华护理杂志,2007,42(1):63-66. 被引量:326
  • 4赵洁.40例白血病患者PICC非计划拔管原因分析与对策[J].中华护理杂志,2007,42(2):174-175. 被引量:51
  • 5Slim K,Nini E,Forestier D,et al. Methodological index for non- randomized studies (minors):development and validation of a new instrument[J]. ANZ J Surg,2003,73(9) :712-716.
  • 6Patel GS, Jain K, Kumar R, et al.Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port- chamber catheters by complication and cost for patients receiving chemotherapy for non- haematological malignancies[ J ]. Support Care Cancer, 2014,22( 1 ) : 121 - 128.
  • 7Schag CC,Heinrich RL,Ganz PA.Karnofsky performance status revisited: reliability, validity, and guidelines [ J ].J Clin Oncol, 1984,2 (3) : 187-193.
  • 8Freire MP, Pierrotti LC,Zerati AE,et al.Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors [J].Infect Control Hosp Epidemiol, 2013,34(7):671-677.
  • 9Lin CH, Wu HS, Chan DC, et al.The mechanisms of failure of totally implantable central venous access system: analysis of 73 cases with fracture of catheter[ J ]. Eur J Surg Oncol, 2010,36( 1 ) : 100- 103.
  • 10Nardueei F, Jean- Laurent M, Boulanger L, et al.Totally implantable venous access port systems and risk factors for complications: a one r year prospective study in a cancer centre [J]. Eur J Surg Oncol, 2011,37(10) :913- 918.

引证文献13

二级引证文献209

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部